These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 17038305

  • 1. Citalopram and suicidality in adult major depression and anxiety disorders.
    Pedersen AG.
    Nord J Psychiatry; 2006; 60(5):392-9. PubMed ID: 17038305
    [Abstract] [Full Text] [Related]

  • 2. Escitalopram therapy for major depression and anxiety disorders.
    Baldwin DS, Reines EH, Guiton C, Weiller E.
    Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424
    [Abstract] [Full Text] [Related]

  • 3. Escitalopram and suicidality in adult depression and anxiety.
    Pedersen AG.
    Int Clin Psychopharmacol; 2005 May; 20(3):139-43. PubMed ID: 15812263
    [Abstract] [Full Text] [Related]

  • 4. A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.
    von Knorring AL, Olsson GI, Thomsen PH, Lemming OM, Hultén A.
    J Clin Psychopharmacol; 2006 Jun; 26(3):311-5. PubMed ID: 16702897
    [Abstract] [Full Text] [Related]

  • 5. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B, Andersen HF, Dolberg OT.
    Depress Anxiety; 2007 Jun; 24(1):53-61. PubMed ID: 16937393
    [Abstract] [Full Text] [Related]

  • 6. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ, Fong R, Kraus JE, Davies JT, Moore C, Thase ME.
    J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
    [Abstract] [Full Text] [Related]

  • 7. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P, Lönn SL, Overø KF.
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [Abstract] [Full Text] [Related]

  • 8. Suicide rates in short-term randomized controlled trials of newer antidepressants.
    Hammad TA, Laughren TP, Racoosin JA.
    J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M.
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [Abstract] [Full Text] [Related]

  • 10. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety.
    Olié JP, Tonnoir B, Ménard F, Galinowski A.
    Depress Anxiety; 2007 May; 24(5):318-24. PubMed ID: 17041922
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and safety of citalopram in hospitalized adolescents with major depression: a preliminary, 8-week, fixed-dose, open-label, prospective study.
    Shoval G, Nahshoni E, Gothelf D, Manor I, Golobchik P, Zemishlany Z, Weizman A, Zalsman G.
    Clin Neuropharmacol; 2011 May; 34(5):182-5. PubMed ID: 21926484
    [Abstract] [Full Text] [Related]

  • 12. Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine.
    Tourian KA, Padmanabhan K, Groark J, Ninan PT.
    J Clin Psychopharmacol; 2010 Aug; 30(4):411-6. PubMed ID: 20631558
    [Abstract] [Full Text] [Related]

  • 13. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.
    JAMA; 2007 Apr 18; 297(15):1683-96. PubMed ID: 17440145
    [Abstract] [Full Text] [Related]

  • 14. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K, Andersen HF, Reines EH.
    Int Clin Psychopharmacol; 2008 Sep 18; 23(5):276-86. PubMed ID: 18703937
    [Abstract] [Full Text] [Related]

  • 15. How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database.
    Baldwin DS, Stein DJ, Dolberg OT, Bandelow B.
    Hum Psychopharmacol; 2009 Jun 18; 24(4):269-75. PubMed ID: 19334042
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov 18; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 17. Effective dose of escitalopram in moderate versus severe DSM-IV major depression.
    Bech P, Andersen HF, Wade A.
    Pharmacopsychiatry; 2006 Jul 18; 39(4):128-34. PubMed ID: 16871468
    [Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
    Fantino B, Moore N, Verdoux H, Auray JP.
    Int Clin Psychopharmacol; 2007 Mar 18; 22(2):107-15. PubMed ID: 17293711
    [Abstract] [Full Text] [Related]

  • 19. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial.
    Chokka P, Legault M.
    Depress Anxiety; 2008 Mar 18; 25(12):E173-81. PubMed ID: 19006260
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
    Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.
    J Clin Psychiatry; 2010 Sep 18; 71(9):1125-30. PubMed ID: 20441723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.